[ad_1]
The corona virus vaccine developed in China, where the first voluntary application at Hacettepe University in Turkey, Prof. Academy of Sciences Dr. Murat Akova gave the good news at the press conference. Prof. Dr. Akova, 1200 health workers, the vaccine would be applied to 13 thousand people in Turkey. Prof. Dr. “This vaccine was administered to 9 thousand people in Brazil. It does not have serious side effects,” Akova said.
According to the DHA report, Rector Prof. Dr. Mehmet Cahit Güran, Director of the Institute of Vaccines Prof. Dr. Serhat Ünal and member of the Academy of Sciences Prof. Dr. Murat Akova held a press conference. Prof. Dr. Ünal drew attention to the fact that the infrastructure must be adequate in the countries where the Phase 3 implementation will take place.
An I “Turkey has this infrastructure. Our 15 years of job education and university hospitals in our face3 started and continued. The ‘Subjects’ field of ‘I ask something bad, our people just use their’ coming concepts like. These voluntarily and , if they are carried out in accordance with the rules that simultaneously Germany While working in Brazil, England, the United States, Chile and Indonesia, it is the work that is carried out taking all kinds of precautions within the framework of the universal rules accepted by very similar countries and voluntarily ”. said.
An I “It cannot be different from what was done there. 25 centers have been identified to support the study. After all the preparations are completed, Hacettepe was the first and will be published gradually in 25 centers. A Phase 3 study will be conducted across the country. When this is over, another vaccine will come. So we will serve humanity. ” We will support the effort to develop a suitable vaccine against this disease that has swept the world. ” said.
Prof. Dr. Ünal stated that there is also a domestic vaccine developed at the Hacettepe University Vaccine Institute, “The animal studies phase is about to start. I hope we get good results from there. We will do Phase 1 and Phase 2 in our own country. We can quickly enter Phase 3 with other countries.” I speak.
‘WE WILL APPLY TO 13 THOUSAND VOLUNTEERS’
Member of the Academy of Sciences of Hacettepe University Prof. Dr. Murat Akova also noted that if Phase 3 is successful, the license will be issued and widely used in society. Prof. Dr. Akova, “We can say that an inactivated vaccine used a virus vaccine which is a killed virus vaccine. Tested in Phase 3 studies around the world it obtained 9 vaccines. These are similar inactivated vaccines, we use 4 of them. Our goal is that 13 thousand people in Turkey carry out this work. That is 13 thousand people in the first phase 1200 people will be health personnel ” I speak.
Akova “We will also divide the group of 1,200 people in two. This will be done completely as ‘blind’ or ‘masked’. So neither we administering the vaccine nor the volunteers receiving the vaccine will divide it. That is, we will give half of this group vaccine and the other half. This is the way to show if the molecule is effective or not. If you show protection against the disease, we will show that this vaccine is effective. While we do it for other volunteers, we will vaccinate 2 people and one person will vaccinate. said.
‘WE WILL SEE IF SIDE EFFECTS ARISE’
Noting that they will continue to monitor the vaccinated volunteers, Akova, “If a certain amount of diseases will occur in the vaccine or in the vaccine volunteers, which we consider between 20 and 40. So we have a separate inspection board, they will see who was vaccinated the actual vaccine, who was vaccinated in this group of diseases”. said.
Akova “If the disease is minor or not seen in the vaccinated group, we will establish that the vaccine is effective as an interim decision, and then we will go back and give them the vaccine again. After vaccination, these people will be screened for 210 days, it is say 7 months. We’ll test them for any effective antimatter. We’ll see if a second immune system activity occurs. Most importantly, we’ll see if there are any side effects. I speak.
‘DAILY RESULTS WILL BE PROCESSED ON THE CARD’
Akova stated that all volunteers will have a card, “They will write their findings on the card daily. They will come to us when they feel a situation. Other than that, we will do routine checkups. This is completely voluntary. The vaccine is given after obtaining signed approval. This is a clinical study. Yes If we knew what the result would be, we would do it with everyone. When we look at the old studies, we see that the results obtained in those studies give us hope. I hope that our hope is confirmed as a result of this study and that we have an effective vaccine. ” used expressions.
‘VOLUNTEERS MUST BE BETWEEN 18 AND 60 YEARS OLD’
Prof. Dr. Murat Akova and Prof. Dr. Serhat Unal answered questions from journalists. Prof. Dr. Akova, regarding who will be subject, “You must be between 18 and 60 years old. You should not have had the disease before. We test and repeat them before vaccination. There must be no pregnancy. We accept volunteers who meet these criteria. We do not accept volunteers over 60 years old. Volunteers they will apply to the vaccination centers. 25 vaccination centers. There are, they will all make these announcements from their website ” said.
‘NO SERIOUS SIDE EFFECTS’
Prof. Dr. Stating that the vaccine has no serious side effects, Akova, “Side effects, side effects to detect in all normal vaccines. The vaccine was administered to 9 thousand people in Brazil. There are no serious side effects among these people. We have intermediate evaluations on days 28 and 42 after the second dose. ¿ Is there a disease? We’ll see if it produces antibodies. I speak.
‘THERE IS NO PROGRESS WHEN THE CODE IS BROKEN’
Prof. Dr. Serhat Ünal, stating that vaccinating 13 thousand people is not a rule “Let’s say we are following those who are sick and will diagnose them at their slightest complaints. If we have broken the code between 20 and 40, then it may not be necessary to continue. When the code is broken, we will come and vaccinate the that we gave them empty vaccines and we will deliver the report that says ‘found safe.’ A thousand okay? We calculated 13 thousand in June, these figures are calculated specifically based on the rate of spread of the disease and the possible protective capacity of the vaccine in that country, I am in the 6th month of surviving this disease. ” said.
‘The pneumonia vaccine does not protect against covid’
Prof. Dr. Serhat Ünal, drawing attention to the pneumonia vaccine lines in family health centers, “The nation stabs itself in order to get vaccinated. The pneumonia vaccine does not protect against covid. It is a different microbe. But if they both happen at the same time, let’s do it by saying ‘your weight may increase’.
Ünal said: “It has been proven for 10 years in the country, ‘For those over 65 to do it or for those who have an underlying chronic disease’. Apart from these, there is no need to do so. If you haven’t done so by today, there’s nothing to wait at the gates. It can be the whole season. I don’t think there is a problem that is not enough. We have 3 factories that produce vaccines all over the world. Someone in Turkey. There are millions of doses of vaccines in stock status. But like thousands of people, the inventory problem is suddenly gone. “ used expressions.
‘EVERYONE OVER 65 YEARS OLD SHOULD HAVE THE FLU VACCINE’
Prof. Dr. Murat Akova, stating that all people over 65 should receive the flu vaccine. “There is a vaccine against influenza and there is a medicine. The Influezna vaccine and the influenza vaccine are very important in terms of the risk group. Everyone over 65 must have it. Other than that, there must be people with chronic diseases regardless of age group. Health personnel should also apply to anyone older than 6 months. vaccine ” said. (Source: DHA)
